CA2397537A1 - External plaster containing 4-biphenylyl acetic acid - Google Patents
External plaster containing 4-biphenylyl acetic acid Download PDFInfo
- Publication number
- CA2397537A1 CA2397537A1 CA002397537A CA2397537A CA2397537A1 CA 2397537 A1 CA2397537 A1 CA 2397537A1 CA 002397537 A CA002397537 A CA 002397537A CA 2397537 A CA2397537 A CA 2397537A CA 2397537 A1 CA2397537 A1 CA 2397537A1
- Authority
- CA
- Canada
- Prior art keywords
- bpaa
- acetic acid
- base material
- adhesive base
- external plaster
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
- A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
- A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
- A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
- A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
- A61K9/7061—Polyacrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
- A61K9/7076—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising ingredients of undetermined constitution or reaction products thereof, e.g. rosin or other plant resins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/42—Use of materials characterised by their function or physical properties
- A61L15/44—Medicaments
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
- A61L2300/21—Acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/402—Anaestetics, analgesics, e.g. lidocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/41—Anti-inflammatory agents, e.g. NSAIDs
Abstract
An aqueous hot melted type adhesive base material containing 4-biphenylyl acetic acid (BPAA) is provided. The adhesive base material contains constant amounts of BPAA and has good drug releasability, so that bioavailability of the drug is enhanced.
An analgesic and anti-inflammatory external plaster containing BPAA is also provided. The plaster is obtained by dissolving BPAA
into an aqueous hot melted type adhesive base material comprising as essential components a styrene-isoprene-styrene block copolymer, an adhesive resin, an antioxidant, lanolin, and water.
An analgesic and anti-inflammatory external plaster containing BPAA is also provided. The plaster is obtained by dissolving BPAA
into an aqueous hot melted type adhesive base material comprising as essential components a styrene-isoprene-styrene block copolymer, an adhesive resin, an antioxidant, lanolin, and water.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP28134699A JP4676042B2 (en) | 1999-10-01 | 1999-10-01 | Topical analgesic / anti-inflammatory patch containing felbinac |
PCT/JP2000/008440 WO2002043729A1 (en) | 1999-10-01 | 2000-11-29 | Analgesic and anti-inflammatory patches for external use containing 4-biphenylylylacetic acid |
Publications (2)
Publication Number | Publication Date |
---|---|
CA2397537A1 true CA2397537A1 (en) | 2002-06-06 |
CA2397537C CA2397537C (en) | 2008-11-18 |
Family
ID=34878901
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002397537A Expired - Fee Related CA2397537C (en) | 1999-10-01 | 2000-11-29 | External plaster containing 4-biphenylyl acetic acid |
Country Status (12)
Country | Link |
---|---|
US (2) | US20030088199A1 (en) |
EP (1) | EP1342472B1 (en) |
JP (1) | JP4676042B2 (en) |
KR (1) | KR100757726B1 (en) |
AT (1) | ATE345789T1 (en) |
AU (1) | AU780735B2 (en) |
CA (1) | CA2397537C (en) |
DE (1) | DE60032032T2 (en) |
DK (1) | DK1342472T3 (en) |
ES (1) | ES2272337T3 (en) |
TW (1) | TWI236904B (en) |
WO (1) | WO2002043729A1 (en) |
Families Citing this family (58)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6300108B1 (en) * | 1999-07-21 | 2001-10-09 | The Regents Of The University Of California | Controlled electroporation and mass transfer across cell membranes |
US6697670B2 (en) * | 2001-08-17 | 2004-02-24 | Minnesota Medical Physics, Llc | Apparatus and method for reducing subcutaneous fat deposits by electroporation with improved comfort of patients |
US8251986B2 (en) * | 2000-08-17 | 2012-08-28 | Angiodynamics, Inc. | Method of destroying tissue cells by eletroporation |
US7130697B2 (en) * | 2002-08-13 | 2006-10-31 | Minnesota Medical Physics Llc | Apparatus and method for the treatment of benign prostatic hyperplasia |
US6994706B2 (en) * | 2001-08-13 | 2006-02-07 | Minnesota Medical Physics, Llc | Apparatus and method for treatment of benign prostatic hyperplasia |
USRE42016E1 (en) | 2001-08-13 | 2010-12-28 | Angiodynamics, Inc. | Apparatus and method for the treatment of benign prostatic hyperplasia |
JP2004277345A (en) * | 2003-03-17 | 2004-10-07 | Daikyo Yakuhin Kogyo Kk | Plaster and method for producing the same |
US20050171574A1 (en) | 2003-12-24 | 2005-08-04 | The Regents Of The University Of California | Electroporation to interrupt blood flow |
JP4443278B2 (en) * | 2004-03-26 | 2010-03-31 | テルモ株式会社 | Catheter with expansion body |
US20060264752A1 (en) * | 2005-04-27 | 2006-11-23 | The Regents Of The University Of California | Electroporation controlled with real time imaging |
US20060293725A1 (en) * | 2005-06-24 | 2006-12-28 | Boris Rubinsky | Methods and systems for treating fatty tissue sites using electroporation |
US20060293731A1 (en) * | 2005-06-24 | 2006-12-28 | Boris Rubinsky | Methods and systems for treating tumors using electroporation |
US8114070B2 (en) * | 2005-06-24 | 2012-02-14 | Angiodynamics, Inc. | Methods and systems for treating BPH using electroporation |
WO2007004833A2 (en) * | 2005-06-30 | 2007-01-11 | Lg Electronics Inc. | Method and apparatus for encoding and decoding an audio signal |
US20070156135A1 (en) * | 2006-01-03 | 2007-07-05 | Boris Rubinsky | System and methods for treating atrial fibrillation using electroporation |
WO2008048620A2 (en) * | 2006-10-16 | 2008-04-24 | The Regents Of The University Of California | Gels with predetermined conductivity used in irreversible electroporation of tissue |
US20080132884A1 (en) * | 2006-12-01 | 2008-06-05 | Boris Rubinsky | Systems for treating tissue sites using electroporation |
US20100004623A1 (en) * | 2008-03-27 | 2010-01-07 | Angiodynamics, Inc. | Method for Treatment of Complications Associated with Arteriovenous Grafts and Fistulas Using Electroporation |
US20090247933A1 (en) * | 2008-03-27 | 2009-10-01 | The Regents Of The University Of California; Angiodynamics, Inc. | Balloon catheter method for reducing restenosis via irreversible electroporation |
US10245098B2 (en) | 2008-04-29 | 2019-04-02 | Virginia Tech Intellectual Properties, Inc. | Acute blood-brain barrier disruption using electrical energy based therapy |
US11272979B2 (en) | 2008-04-29 | 2022-03-15 | Virginia Tech Intellectual Properties, Inc. | System and method for estimating tissue heating of a target ablation zone for electrical-energy based therapies |
US9283051B2 (en) | 2008-04-29 | 2016-03-15 | Virginia Tech Intellectual Properties, Inc. | System and method for estimating a treatment volume for administering electrical-energy based therapies |
US10238447B2 (en) | 2008-04-29 | 2019-03-26 | Virginia Tech Intellectual Properties, Inc. | System and method for ablating a tissue site by electroporation with real-time monitoring of treatment progress |
US10117707B2 (en) | 2008-04-29 | 2018-11-06 | Virginia Tech Intellectual Properties, Inc. | System and method for estimating tissue heating of a target ablation zone for electrical-energy based therapies |
US10702326B2 (en) | 2011-07-15 | 2020-07-07 | Virginia Tech Intellectual Properties, Inc. | Device and method for electroporation based treatment of stenosis of a tubular body part |
US11254926B2 (en) | 2008-04-29 | 2022-02-22 | Virginia Tech Intellectual Properties, Inc. | Devices and methods for high frequency electroporation |
US9598691B2 (en) | 2008-04-29 | 2017-03-21 | Virginia Tech Intellectual Properties, Inc. | Irreversible electroporation to create tissue scaffolds |
US8992517B2 (en) * | 2008-04-29 | 2015-03-31 | Virginia Tech Intellectual Properties Inc. | Irreversible electroporation to treat aberrant cell masses |
US10272178B2 (en) | 2008-04-29 | 2019-04-30 | Virginia Tech Intellectual Properties Inc. | Methods for blood-brain barrier disruption using electrical energy |
US9867652B2 (en) | 2008-04-29 | 2018-01-16 | Virginia Tech Intellectual Properties, Inc. | Irreversible electroporation using tissue vasculature to treat aberrant cell masses or create tissue scaffolds |
US9198733B2 (en) | 2008-04-29 | 2015-12-01 | Virginia Tech Intellectual Properties, Inc. | Treatment planning for electroporation-based therapies |
WO2009137800A2 (en) * | 2008-05-09 | 2009-11-12 | Angiodynamics, Inc. | Electroporation device and method |
WO2009155526A2 (en) * | 2008-06-20 | 2009-12-23 | Angiodynamics, Inc. | Device and method for the ablation of fibrin sheath formation on a venous catheter |
US9681909B2 (en) * | 2008-06-23 | 2017-06-20 | Angiodynamics, Inc. | Treatment devices and methods |
US20100152725A1 (en) * | 2008-12-12 | 2010-06-17 | Angiodynamics, Inc. | Method and system for tissue treatment utilizing irreversible electroporation and thermal track coagulation |
WO2010085765A2 (en) * | 2009-01-23 | 2010-07-29 | Moshe Meir H | Therapeutic energy delivery device with rotational mechanism |
WO2010093692A2 (en) * | 2009-02-10 | 2010-08-19 | Hobbs Eamonn P | Irreversible electroporation and tissue regeneration |
US11382681B2 (en) | 2009-04-09 | 2022-07-12 | Virginia Tech Intellectual Properties, Inc. | Device and methods for delivery of high frequency electrical pulses for non-thermal ablation |
US11638603B2 (en) | 2009-04-09 | 2023-05-02 | Virginia Tech Intellectual Properties, Inc. | Selective modulation of intracellular effects of cells using pulsed electric fields |
WO2010118387A1 (en) * | 2009-04-09 | 2010-10-14 | Virginia Tech Intellectual Properties, Inc. | Integration of very short electric pulses for minimally to noninvasive electroporation |
USD630321S1 (en) | 2009-05-08 | 2011-01-04 | Angio Dynamics, Inc. | Probe handle |
WO2010138919A2 (en) | 2009-05-28 | 2010-12-02 | Angiodynamics, Inc. | System and method for synchronizing energy delivery to the cardiac rhythm |
US9895189B2 (en) | 2009-06-19 | 2018-02-20 | Angiodynamics, Inc. | Methods of sterilization and treating infection using irreversible electroporation |
US20110118732A1 (en) | 2009-11-19 | 2011-05-19 | The Regents Of The University Of California | Controlled irreversible electroporation |
WO2012051433A2 (en) | 2010-10-13 | 2012-04-19 | Angiodynamics, Inc. | System and method for electrically ablating tissue of a patient |
JP5856975B2 (en) | 2010-11-02 | 2016-02-10 | 帝國製薬株式会社 | Topical patch containing felbinac |
WO2012088149A2 (en) | 2010-12-20 | 2012-06-28 | Virginia Tech Intellectual Properties, Inc. | High-frequency electroporation for cancer therapy |
US9078665B2 (en) | 2011-09-28 | 2015-07-14 | Angiodynamics, Inc. | Multiple treatment zone ablation probe |
US9414881B2 (en) | 2012-02-08 | 2016-08-16 | Angiodynamics, Inc. | System and method for increasing a target zone for electrical ablation |
AU2015259303B2 (en) | 2014-05-12 | 2021-10-28 | Arena, Christopher B. | Selective modulation of intracellular effects of cells using pulsed electric fields |
CN104262138B (en) * | 2014-08-22 | 2016-05-11 | 湖北美林药业有限公司 | A kind of felbinac compound and pharmaceutical composition thereof |
US10694972B2 (en) | 2014-12-15 | 2020-06-30 | Virginia Tech Intellectual Properties, Inc. | Devices, systems, and methods for real-time monitoring of electrophysical effects during tissue treatment |
CN106822049B (en) * | 2015-12-07 | 2020-10-20 | 北京乳凝创智生物技术研发中心(有限合伙) | Novel chemical medicine patch ketoprofen patch and preparation method thereof |
US10905492B2 (en) | 2016-11-17 | 2021-02-02 | Angiodynamics, Inc. | Techniques for irreversible electroporation using a single-pole tine-style internal device communicating with an external surface electrode |
US11607537B2 (en) | 2017-12-05 | 2023-03-21 | Virginia Tech Intellectual Properties, Inc. | Method for treating neurological disorders, including tumors, with electroporation |
US11311329B2 (en) | 2018-03-13 | 2022-04-26 | Virginia Tech Intellectual Properties, Inc. | Treatment planning for immunotherapy based treatments using non-thermal ablation techniques |
US11925405B2 (en) | 2018-03-13 | 2024-03-12 | Virginia Tech Intellectual Properties, Inc. | Treatment planning system for immunotherapy enhancement via non-thermal ablation |
US11950835B2 (en) | 2019-06-28 | 2024-04-09 | Virginia Tech Intellectual Properties, Inc. | Cycled pulsing to mitigate thermal damage for multi-electrode irreversible electroporation therapy |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5374537A (en) | 1976-12-13 | 1978-07-03 | Dai Ichi Kogyo Seiyaku Co Ltd | Softener for pressure-sensitive adhesive |
JPS54101420A (en) * | 1978-01-25 | 1979-08-10 | Nitto Electric Ind Co Ltd | Poultice and its preparation |
JPS5826888B2 (en) * | 1979-03-26 | 1983-06-06 | 日東電工株式会社 | poultice |
JPS593966B2 (en) * | 1979-09-04 | 1984-01-27 | 日東電工株式会社 | patch |
US4398985A (en) * | 1980-02-08 | 1983-08-16 | Kimberly-Clark Corporation | Releasable, self-detackifying laminate construction |
JPH0614957B2 (en) * | 1983-06-20 | 1994-03-02 | 帝国製薬株式会社 | Tape-shaped hydrous patch and method for producing the same |
JP3723229B2 (en) * | 1991-03-12 | 2005-12-07 | 武田薬品工業株式会社 | External patch |
JP3541849B2 (en) * | 1991-04-19 | 2004-07-14 | 久光製薬株式会社 | Anti-inflammatory analgesic patch |
JPH062253A (en) * | 1992-06-18 | 1994-01-11 | Barudan Co Ltd | Embroidery hoop |
JPH0624969A (en) * | 1992-07-09 | 1994-02-01 | Teikoku Seiyaku Co Ltd | Ketoprofen-containing cataplasm |
CA2274120A1 (en) * | 1996-12-06 | 1998-06-11 | Hisamitsu Pharmaceuticals Co., Inc. | Plaster containing felbinac |
US6471984B1 (en) * | 1998-01-14 | 2002-10-29 | Hisamitsu Pharmaceutical Co., Inc. | Cataplasm and tape-aid containing a plasticizer |
KR100803010B1 (en) * | 2000-11-29 | 2008-02-14 | 데이고꾸세이약꾸가부시끼가이샤 | Adhesive preparation for external use |
-
1999
- 1999-10-01 JP JP28134699A patent/JP4676042B2/en not_active Expired - Fee Related
-
2000
- 2000-11-29 US US10/203,276 patent/US20030088199A1/en not_active Abandoned
- 2000-11-29 ES ES00978012T patent/ES2272337T3/en not_active Expired - Lifetime
- 2000-11-29 DK DK00978012T patent/DK1342472T3/en active
- 2000-11-29 EP EP00978012A patent/EP1342472B1/en not_active Expired - Lifetime
- 2000-11-29 CA CA002397537A patent/CA2397537C/en not_active Expired - Fee Related
- 2000-11-29 KR KR1020027009683A patent/KR100757726B1/en not_active IP Right Cessation
- 2000-11-29 AU AU15545/01A patent/AU780735B2/en not_active Ceased
- 2000-11-29 AT AT00978012T patent/ATE345789T1/en not_active IP Right Cessation
- 2000-11-29 DE DE60032032T patent/DE60032032T2/en not_active Expired - Lifetime
- 2000-11-29 WO PCT/JP2000/008440 patent/WO2002043729A1/en active IP Right Grant
- 2000-12-05 TW TW089125895A patent/TWI236904B/en not_active IP Right Cessation
-
2005
- 2005-09-06 US US11/218,568 patent/US7276641B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
US7276641B2 (en) | 2007-10-02 |
JP4676042B2 (en) | 2011-04-27 |
KR20020079811A (en) | 2002-10-19 |
CA2397537C (en) | 2008-11-18 |
TWI236904B (en) | 2005-08-01 |
EP1342472A1 (en) | 2003-09-10 |
US20030088199A1 (en) | 2003-05-08 |
DE60032032D1 (en) | 2007-01-04 |
EP1342472A4 (en) | 2005-09-28 |
WO2002043729A1 (en) | 2002-06-06 |
AU1554501A (en) | 2002-06-11 |
KR100757726B1 (en) | 2007-09-11 |
ATE345789T1 (en) | 2006-12-15 |
US20060015054A1 (en) | 2006-01-19 |
JP2001097857A (en) | 2001-04-10 |
ES2272337T3 (en) | 2007-05-01 |
DE60032032T2 (en) | 2007-05-31 |
DK1342472T3 (en) | 2007-01-15 |
EP1342472B1 (en) | 2006-11-22 |
AU780735B2 (en) | 2005-04-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2397537A1 (en) | External plaster containing 4-biphenylyl acetic acid | |
IS7497A (en) | (1a, 3a, 5a) (3-Aminomethyl bicyclo [3.2.0] hept-3-yl) l-acetic acid, pharmaceutical formulations and use of a compound for the manufacture of pharmaceuticals | |
AU2001288998A1 (en) | Pharmaceutical formulations containing a non-steroidal antiinflammatory drug anda proton pump inhibitor | |
DE69811236D1 (en) | A MEDICINAL PRODUCT CONTAINING SHOWER ACID BASE COUPLE | |
CA2327723A1 (en) | Bicyclic hydroxamic acid derivatives | |
HK1058143A1 (en) | Analgesic/antiinflammatory patches for topical use | |
AU6404398A (en) | New derivatives of 2-(iminomethyl)amino-phenyl, their preparation, their use as medicaments and the pharmaceutical compositions containing them | |
IT8522493A0 (en) | OBTAINED. PROCEDURE FOR THE PREPARATION OF TABLETS, EVEN WITH EXTENDED RELEASE, OF STABILIZED ISOSORBIDE-5-MONONITRATE AND FORMULATIONS SO | |
CA2391076A1 (en) | Solutions containing epinastin | |
EA200001201A3 (en) | Matrix tablet for prolonged release of trimetazidine | |
CA2083639A1 (en) | Substituted phenyl phenol leukotriene antagonists | |
CA2340054A1 (en) | Oral administration form for pyridin-2-ylmethylsulfinyl-1h-benzimidazoles | |
CA2350659A1 (en) | Pharmaceutical composition for modified release insulin sensitiser | |
CA2281054A1 (en) | Combination of zinc ions and vitamin c and method of making | |
CA2380128A1 (en) | Plasters containing 4-biphenylacetic acid | |
CA2386423A1 (en) | Pharmaceutical compositions containing copper, salicylic acid and vitamines c | |
AU656674B2 (en) | New thiochroman compounds, processes for the preparation thereof, and pharmaceutical compositions containing them | |
AU9270598A (en) | Hydrazono-benzazulene derivatives, pharmaceutical compositions and in termediates | |
AU1643592A (en) | Novel compound and use of the same as medicine | |
CA2397546A1 (en) | External plaster | |
EP0976397A3 (en) | Improved release of ibuprofen from pressure-sensitive hot melt adhesives by the addition of pharmaceutical excipients | |
MY122830A (en) | Process for the preparation of (alpha)-(2-4-disulfophenyl)-n-tert-butylnitrone and pharmaceutically acceptable salts thereof | |
IL108246A0 (en) | Nonatetraenoic acid derivates, their preparation and pharmaceutical compositions containing them | |
DK0937727T3 (en) | Process for the preparation of soluble crystalline cefuroxime axetil | |
CA2239313A1 (en) | Solid compound, its preparation and use in medicine |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EEER | Examination request | ||
MKLA | Lapsed |
Effective date: 20161129 |